Clinical Trial Update: Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating allogeneic peripheral stem cell transplantation for Stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Allogeneic peripheral stem cell transplantation

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED